title: Transcatheter valve implantation for calcific mitral valve disease.
abstract: Transcatheter treatment of calcific mitral valve disease with commercially available balloon-expandable valves is feasible Current clinical outcomes are suboptimal, consequently this should be considered only in severely symptomatic patients without other options Purpose-specific mitral valves may allow for this therapy to achieve its full potential.
authors.affiliation: St Paul's Hospital, University of British Columbia, Vancouver, Canada.
authors.forename: John G
authors.initials: JG
authors.lastname: Webb
authors.affiliation: St Paul's Hospital, University of British Columbia, Vancouver, Canada.
authors.forename: Danny
authors.initials: D
authors.lastname: Dvir
mesh_terms: D006328:Cardiac Catheterization; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008943:Mitral Valve / Q000601:surgery*; D011474:Prosthesis Design; D016896:Treatment Outcome